Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Scientific Reports
|
June 13, 2015
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer
Moumita Chatterjee, Edgar Ben-Josef, Dafydd G Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2019
Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer
Kyle C Cuneo, Meredith A Morgan, Vaibhav Sahai, et al.
Molecular Cancer Research : MCR
|
March 29, 2022
DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer
Weiwei Wang, Matthew T McMillan, Xinyi Zhao, et al.
The Journal of Biological Chemistry
|
March 11, 2026
ISGylation of γH2AX retains MDC1 and facilitates homologous recombination repair causing radioresistance in esophageal adenocarcinoma
Archismaan Ghosh, Paramita Ray, Dafydd Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2013
Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776
Carl G Engelke, Leslie A Parsels, Yushen Qian, et al.
Cancer Research
|
December 8, 2016
Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis
Daniel R Wahl, Joseph Dresser, Kari Wilder-Romans, et al.
Cancer Research
|
May 27, 2010
Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair
Meredith A Morgan, Leslie A Parsels, Lili Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2011
Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibition
Leslie A Parsels, Yushen Qian, Daria M Tanska, et al.
Cancer Research
|
May 19, 2019
Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy
Qiang Zhang, Michael D Green, Xueting Lang, et al.
Nature Metabolism
|
July 23, 2020
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours
Ziwen Zhu, Abhinav Achreja, Noah Meurs, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Scientific Reports
|
June 13, 2015
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer
Moumita Chatterjee, Edgar Ben-Josef, Dafydd G Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2019
Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer
Kyle C Cuneo, Meredith A Morgan, Vaibhav Sahai, et al.
Molecular Cancer Research : MCR
|
March 29, 2022
DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer
Weiwei Wang, Matthew T McMillan, Xinyi Zhao, et al.
The Journal of Biological Chemistry
|
March 11, 2026
ISGylation of γH2AX retains MDC1 and facilitates homologous recombination repair causing radioresistance in esophageal adenocarcinoma
Archismaan Ghosh, Paramita Ray, Dafydd Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2013
Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776
Carl G Engelke, Leslie A Parsels, Yushen Qian, et al.
Cancer Research
|
December 8, 2016
Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis
Daniel R Wahl, Joseph Dresser, Kari Wilder-Romans, et al.
Cancer Research
|
May 27, 2010
Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair
Meredith A Morgan, Leslie A Parsels, Lili Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2011
Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibition
Leslie A Parsels, Yushen Qian, Daria M Tanska, et al.
Cancer Research
|
May 19, 2019
Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy
Qiang Zhang, Michael D Green, Xueting Lang, et al.
Nature Metabolism
|
July 23, 2020
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours
Ziwen Zhu, Abhinav Achreja, Noah Meurs, et al.
Page
of 8